Also trades as: SLXN (NASDAQ) · $vol 0M
SLXNW NASDAQ
Silexion Therapeutics Ltd.
1W: -15.9%
1M: -47.8%
3M: -68.6%
YTD: -72.3%
1Y: -82.0%
$0.02
+0.01 (+84.26%)
Weekly Expected Move ±107.6%
$-0
$-0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Last Earnings
2026-03-17
EPS
$-2.38
▼ Miss -112.9%
Revenue
—
Next Earnings
2026-08-18
EPS Estimate
$-1.31
Range: $-1.31 - $-1.31
Estimate vs Actual
Earnings Surprise History
2/4
EPS Beats
0/4
Revenue Beats
50%
EPS Beat Rate
0%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-03-25 | annual | 2030-12-31 | $0.01 | $-0.39 | ▼ 0.39 | $34,989,000 | $34,989,000 |
| 2026-03-25 | annual | 2029-12-31 | $-1.77 | $-2.54 | ▼ 0.77 | $— | $— |
| 2026-03-25 | annual | 2028-12-31 | $-2.33 | $-2.67 | ▼ 0.33 | $— | $— |
| 2026-03-25 | annual | 2027-12-31 | $-3.12 | $-2.23 | ▲ 0.89 | $— | $— |
| 2026-03-23 | annual | 2026-12-31 | $-4.25 | $-4.12 | ▲ 0.12 | $— | $— |
| 2026-03-20 | annual | 2030-12-31 | $— | $0.01 | — | $— | $34,989,000 |
| 2026-03-20 | quarter | 2026-06-30 | $— | $-1.31 | ▼ 1.31 | $— | $— |
| 2026-03-20 | annual | 2029-12-31 | $-1.62 | $-1.77 | ▼ 0.15 | $— | $— |
| 2026-03-20 | quarter | 2026-09-30 | $— | $-1.33 | ▼ 1.33 | $— | $— |
| 2026-03-20 | annual | 2028-12-31 | $-2.18 | $-2.33 | ▼ 0.16 | $— | $— |
| 2026-03-20 | quarter | 2025-12-31 | $— | $-1.12 | ▼ 1.12 | $— | $— |
| 2026-03-20 | annual | 2026-12-31 | $-3.84 | $-4.25 | ▼ 0.40 | $— | $— |
| 2026-03-20 | quarter | 2026-03-31 | $— | $-1.29 | ▼ 1.29 | $— | $— |
| 2026-03-20 | quarter | 2026-12-31 | $— | $-0.50 | ▼ 0.50 | $— | $— |
| 2026-03-20 | annual | 2027-12-31 | $-3.00 | $-3.12 | ▼ 0.12 | $— | $— |
Earnings Call Transcripts
No transcripts available.